SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Steve Fancy who wrote (4759)7/6/1998 3:13:00 PM
From: Intel Trader  Read Replies (2) of 6136
 
nah. AGPH is OVERSOLD. We held 25ish, AGPH is coming off its low at 25 1/8, having held support with good volume. The last time we've been here was OCT 96.
I'd never say that 22 1/2 isn't a possiblity, but I do think it is *highly* unlikely. Look for a bounce here.

it

Just called IR. Claudia said that the company sees no reason why the AGPH's share price has gotten this low.

Phone: 619-622-3000
Fax: 619-622-3298
Web Site: agouron.com

CEO: Peter Johnson
CFO: Steven S. Cowell
HR: Pat Moses
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext